Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 6/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 5/20 | 1.00 |
| ▸ | TRPV1 | Q8NER1 | 5/20 | 1.00 |
| ▸ | CYP2C8 | P10632 | 4/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 4/20 | 1.00 |
| ▸ | CYP2B6 | P20813 | 4/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 4/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 3/20 | 1.00 |
| ▸ | HTR1A | P08908 | 3/20 | 0.98 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.98 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.98 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.98 |
| ▸ | POLB | P06746 | 1/20 | 0.72 |
| ▸ | GAA | P10253 | 1/20 | 0.72 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.61 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Gingerol SCHEMBL17368634 | 1.00 | LTA4H (1.00) | LTA4HCYP3A4TRPV1CYP2C8CYP2C9 | |
| Gingerol SCHEMBL2121898 | 1.00 | LTA4H (1.00) | LTA4HCYP3A4TRPV1CYP2C8CYP2C9 | |
| Gingerol SCHEMBL32102 | 1.00 | LTA4H (1.00) | LTA4HCYP3A4TRPV1CYP2C8CYP2C9 | |
| Gingerol SCHEMBL29475335 | 1.00 | LTA4H (1.00) | LTA4HCYP3A4TRPV1CYP2C8CYP2C9 | |
| SCHEMBL17301613 | 0.99 | LTA4H (1.00) | LTA4HCYP3A4TRPV1CYP2C8CYP2C9 | |
| SCHEMBL20668234 | 0.99 | LTA4H (1.00) | LTA4HCYP3A4TRPV1CYP2C8CYP2C9 | |
| SCHEMBL17301612 | 0.99 | LTA4H (1.00) | LTA4HCYP3A4TRPV1CYP2C8CYP2C9 | |
| SCHEMBL20668179 | 0.99 | LTA4H (1.00) | LTA4HCYP3A4TRPV1CYP2C8CYP2C9 | |
| SCHEMBL4883453 | 0.99 | LTA4H (1.00) | LTA4HCYP3A4TRPV1CYP2C8CYP2C9 | |
| SCHEMBL4885722 | 0.99 | LTA4H (1.00) | LTA4HCYP3A4TRPV1CYP2C8CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11904047-B1 | Formulation and delivery systems for herbal compositions for the treatment of canker sores (recurrent aphthous stomatitis) and related conditions | TRAN SANDIE (US) | 2024-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11904047-B1 | Formulation and delivery systems for herbal compositions for the treatment of canker sores (recurrent aphthous stomatitis) and related conditions | TAS2R46, IL6, TAS2R8 | LTA4H 1716/4885CYP3A4 1182/4885TRPV1 364/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.